ACCUTRAK DELIVERY CATHETER SYSTEM
Report
- Report Number
- 2025587-2017-02278
- Event Type
- Injury
- Date Received
- November 28, 2017
- Date of Event
- September 2, 2015
- Report Date
- November 28, 2017
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- NPT
- PMA / PMN Number
- P130021
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SW
- Reporter Occupation
- PHYSICIAN
Narratives
CITATION: SALEH, N. MD ET AL. FEMORAL ACCESS-RELATED COMPLICATIONS DURING PERCUTANEOUS TRANSCATHETER AORTIC VALVE IMPLANTATION COMPARING SINGLE VERSUS DOUBLE PROSTAR XL DEVICE CLOSURE. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2015) 86:1255¿1261 DOI 10.1002/CCD.25966 EARLIEST DATE OF E-PUBLISH/PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION, IT CANNOT BE DETERMINED WHETHER THIS EVENT HAS BEEN PREVIOUSLY REPORTED.
MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REVIEW REGARDING ACCESS SITE CLOSURE OUTCOMES WITH THE USE OF CLOSURE DEVICES AFTER THE IMPLANT OF A TRANSCATHETER AORTIC VALVE. ALL DATA WERE COLLECTED FROM A SINGLE CENTER BETWEEN 2012 AND 2014. THE STUDY POPULATION INCLUDED 126 PATIENTS, ALL OF WHICH WERE IMPLANTED WITH A COREVALVE. SERIAL NUMBERS WERE NOT PROVIDED. THE STUDY POPULATION WAS PREDOMINANTLY MALE; MEAN AGE 83 ±6 YEARS AMONG ALL PATIENTS ADVERSE EVENTS INCLUDED: VASCULAR COMPLICATIONS AND BLOOD LOSS. BASED ON THE AVAILABLE INFORMATION, THESE EVENTS MAY HAVE BEEN ATTRIBUTED TO A MEDTRONIC PRODUCT OR MAY HAVE BEEN DUE TO THE CLOSURE DEVICE. A DIRECT CORRELATION COULD NOT BE MADE BETWEEN THE OBSERVED ADVERSE EVENTS AND THE MEDTRONIC PRODUCT. NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 844421 | ACCUTRAK DELIVERY CATHETER SYSTEM | AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED | NPT | MEDTRONIC HEART VALVES DIVISION | DCS | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 83 YR | Life Threatening |